Moderna vaccine trial shows 94.5% effectiveness

Just a week after promising news from its competitor Pfizer, pharmaceutical giant Moderna is reporting success in its own clinical trials. As Seán O’Shea reports, the company says its vaccine showed 94.5 per cent effectiveness in tests.